Rooks & Garrett (2016, Nat Rev Immunol ) describe SCFAs as central immune-metabolic regulators
Professor Receives Grant to Study Effectiveness of GLP-1 Weight-Loss Drugs Andrew Stokes, associate professor of global health, has received a grant from the Robert Wood Johnson Foundation to analyze the real-world effectiveness of this new class of therapies and inequities in access to these medications
I hold space for those feelings, and help you build body respect even if body positivity feels out of reach
Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis1
Obesity and dietitian societies have issued a joint consensus statement on the use of obesity drugs for weight-loss treatment, which highlights the role of dietitians in medical nutritional therapy, psychological vulnerabilities that may exist around weight loss, the importance of physical activity and other socioeconomic factors that should be considered 47
Reduced Saliva Production: One of the most significant factors contributing to Ozempic teeth is dry mouth
